Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.
On Wednesday, Defense Secretary Pete Hegseth made the startling announcement that the US military would begin requiring all ...
The defense secretary’s idea of administering testosterone therapy to members of the US Armed Forces reveals little ...
Modern anticancer medications that combine tumor-fighting drugs with proteins that specifically target cancer cells are a ...
The FDA just approved a new drug for use in ER+/HER2- metastatic breast cancer, based on a large study led by Fred Hutch's Dr ...
Several children who had aggressive recurrent brain tumors remained disease-free years after this treatment, according to an ...
Targeting mutant KRAS may offer a promising new treatment option for appendix cancer, according to research from The ...
Modern anticancer medications that combine tumor-fighting drugs with proteins that specifically target cancer cells are a relatively new class of drug, often given to patients for whom standard ...
Researchers @hopkinskimmel and @HopkinsMed develop methods to predict which #livercancer patients do best with combination ...
Camurus (NASDAQ STO: CAMX) today announced that the US Food and Drug Administration (FDA) has accepted for review the resubmission of the New Drug Application (NDA) for CAM2029, octreotide ...
WSW, NY, July 15th, 2026, FinanceWireOn July 6, 2026, Vertex Pharmaceuticals (NASDAQ: VRTX) agreed to acquire Crinetics ...